Acute Pancreatitis Clinical Trial
Official title:
Assessment of the Different Etiological and Susceptibility Markers in Patients With Pancreatitis: Investigating IG4, Cytomegalovirus, Coxsackie- Virus, Genetic Polymorphism of Vitamin D Receptor Gene
Acute pancreatitis (AP) is a multifactorial disease. AP represents a significant number of hospital admissions. Most of the patients are admitted in an acute setting. Early identification of its etiology is an essential step toward the rational approach, both for its implications in the immediate therapy and the prevention of recurrence. Although often obvious, the etiological workup of acute pancreatitis can be challenging.
Acute pancreatitis is the most common pancreatic disorder. Although acute pancreatitis is a
benign disease, it often progresses to a serious state, and mortality is still high.
Autoimmune pancreatitis (AIP) was first used to describe cases of pancreatitis with narrowing
of the pancreatic duct, enlargement of the pancreas, hyper-γ-globulinaemia, and antinuclear
antibody (ANA) positivity serologically by indirect immunofluorescence (IIF). The main
differential diagnosis is pancreatic cancer, which can be ruled out through radiological,
serological, and histological investigations.
Cytomegalovirus (CMV) is a common viral pathogen in humans. It is a lytic virus that causes a
cytopathic effect in vitro and in vivo. Seroprevalence for CMV worldwide ranges from 60%-100%
but the severity of illness varies. Primary CMV may be asymptomatic or may cause a mild and
self-limiting mononucleosis-like syndrome. The self-limiting course of CMV infection
typically includes fever, malaise, splenomegaly, mild hepatomegaly, small increases in serum
transaminase activity, and variable elevation of serum alkaline phosphatase. CMV infection
can cause severe hepatitis, meningitis, encephalitis, myelitis, colitis, pancreatitis and
pneumonitis. Coxsackie-B virus can also cause acute pancreatitis.
VDR are also expressed on pancreatic Ɓ cells, and may play an essential role in maintaining
normal insulin levels in accordance to glucose concentrations and to maintain glucose
tolerance. Because vitamin D acts through VDR, their impairment or reduced functionality,
e.g., as a result of polymorphisms occurring in the VDR gene, may have a crucial impact on
the balance in the vitamin D concentration in the circulation, and the final metabolite
activity throughout the body.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT05410795 -
Establishment and Verification of Pancreatic Volume Formula Based on Imaging
|
||
Recruiting |
NCT04195347 -
Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase
|
Phase 1/Phase 2 | |
Completed |
NCT04735055 -
Artificial Intelligence Prediction for the Severity of Acute Pancreatitis
|
||
Completed |
NCT02928718 -
The Association Between Post-ERCP Acute Pancreatitis and Various Genetic Mutations
|
||
Terminated |
NCT02885441 -
Treatment of Acute Pancreatitis With Ketorolac
|
Phase 4 | |
Completed |
NCT02563080 -
Pancreatic Exocrine Insufficiency in Acute Pancreatitis
|
||
Recruiting |
NCT01626911 -
Continuous Regional Arterial Infusion of Low Molecular Weight Heparin in Patients With Severe Acute Pancreatitis
|
N/A | |
Completed |
NCT01507766 -
The Correlations Between Early Enteral Nutrition and Intra-abdominal Pressure in Severe Acute Pancreatitis
|
Phase 4 | |
Completed |
NCT04901949 -
The Course of Acute Pancreatitis in Patients With Different BMI Groups
|
||
Recruiting |
NCT04814693 -
Conventional Endoscopic Techniques Versus EndoRotor® System for Necrosectomy of Walled of Necrosis
|
N/A | |
Completed |
NCT02743364 -
Simvastatin in Reducing Pancreatitis in Patients With Recurrent, Acute or Chronic Pancreatitis
|
Phase 2 | |
Recruiting |
NCT05281458 -
Early Versus Standard Endoscopic Interventions for Peripancreatic Fluid Collections
|
N/A | |
Not yet recruiting |
NCT04990336 -
Dachaihu Decoction Compound and Rhubarb Single Medicine in the Treatment of Acute Pancreatitis
|
N/A | |
Not yet recruiting |
NCT03259880 -
Searching the Best Prognostic Factor in Out Come Evaluation in Patients With Acute Pancreatitis Admitted at Assiut University Hospitals
|
N/A | |
Completed |
NCT02543658 -
Neostigmine Treatment of Acute Pancreatitis Combined With Intra-abdominal Hypertension
|
Phase 2 | |
Recruiting |
NCT06023771 -
Invasive Intervention of Local Complications of Acute Pancreatitis
|
||
Not yet recruiting |
NCT05501314 -
Remote Home Monitoring Acute Pancreatitis
|
N/A | |
Completed |
NCT02897206 -
Imipenem Prophylaxis in Patients With Acute Pancreatitis
|
Phase 4 | |
Recruiting |
NCT03634787 -
Heat Shock Proteins: a Pathogenic Driver and Potential Therapeutic Target in Acute Pancreatitis
|
||
Active, not recruiting |
NCT04989166 -
Effect of Nano-curcumin Supplementation in Acute Pancreatitis
|
N/A |